Status:
COMPLETED
Dog-Assisted Therapy for Children and Adolescents With FASD
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
FASD
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The rationale of the present study was to evaluate the efficacy of DAT in children and adolescents with FASD in relation to its effects on social skills, internalized and externalized symptomatology a...
Detailed Description
The rationale of this study was to evaluate the efficacy of Dog Assisted Therapy in children and adolescents with FASD. The investigators conducted a randomized, rater-blinded, controlled pilot trial ...
Eligibility Criteria
Inclusion
- Patients diagnosed with FASD between 6 and 18 years (FAS, pFAS or ARND)
- With or without comorbidities
- Stabilized doses of medication for at least 2 months before the study
- Patients with borderline IQ or mental retardation.
Exclusion
- Patients who were not behaviorally stable
- Patients that required hospitalization, day hospital or more intensive treatments.
Key Trial Info
Start Date :
April 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 2 2019
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04038164
Start Date
April 2 2018
End Date
April 2 2019
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall d'Hebron Research Institute
Barcelona, Spain, 08035